Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51dd24b692ace975be34b3f6d3719823 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711 |
filingDate |
2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9b1a3a6cb89f7284ae57bd7120cfd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6d7e8b1866f3b1e0b5fece4cf15fd7 |
publicationDate |
2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008213348-A1 |
titleOfInvention |
Agents for gene therapy of cerebrovascular disorders |
abstract |
The present invention provides novel methods for treating cerebrovascular disorders, in which HGF is overexpressed by introducing an HGF gene. The methods of this invention using an HGF gene enable active treatment of cerebrovascular disorders, such as cerebral infarction, by gene transfer, and enable the maintenance of neuronal function and the suppression of infarcted areas in patients for whom appropriate treatment methods were unavailable until now. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007264321-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011045061-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008268030-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939504-B2 |
priorityDate |
2002-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |